Kevin Troy, MD
-
- Position
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
-
- Specialties
- Hematology-Oncology
- Cancer (Oncology)
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Beth Israel
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
-
- Phone
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
-
Ruttenberg Treatment Center
1470 Madison Avenue
3rd Floor
New York, NY 10029
Phone: 212-241-6756212-241-6756
Kevin Troy, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He treats patients with many types of cancer and conditions, including coagulation disorders, anemia, thrombosis, lymphomas, chronic leukemias, and myelodysplastic syndromes. He has had a long-time clinical practice at Mount Sinai since joining the faculty in 1984. Dr. Troy sees patients at The Ruttenberg Treatment Center.
Dr. Troy has served on committees at the Icahn School of Medicine overseeing medical school admissions and graduate medical education, and was Assistant Dean and subsequently Associate Dean of Graduate Medical Education for more than 25 years. He has also been involved in clinical operations, serving on the Laboratory Committee and Pharmacy Committee.
Dr. Troy is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the International Society of Thrombosis and Haemostasis.
Certifications
Hematology
American Board of Internal Medicine
Clinical Focus
- Coagulation Disorders
- Essential Thrombocythemia
- Hairy Cell Leukemia
- Hematology
- Hemophilia
- Hodgkin's Disease
- Hodgkin's Lymphoma
- Lymphoma
- Myelodysplastic Syndromes
- Waldenström's Macroglobulinemia
Education
MD, University of Connecticut
Residency, Internal Medicine
Lenox Hill Hospital
Fellowship, Hematology
The Mount Sinai Hospital
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Troy did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.